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Abstract 
Objectives: This study aimed to investigate dose-response between frequency of breaks in sedentary time 
and glucose control. 
Design: Randomised three-treatment, two-period balanced incomplete block trial. AC
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Methods: Twelve adults with type 2 diabetes (age, 60±11 years; body mass index, 30.2±4.7 kg/m2) 
participated in two of the following treatment conditions: sitting for 7 hours interrupted by 3 min light-
intensity walking breaks every (1) 60 min (Condition 1), (2) 30 min (Condition 2), and (3) 15 min 
(Condition 3). Postprandial glucose incremental area under the curves (iAUCs) and 21-h glucose total 
area under the curve (AUC) were measured using continuous glucose monitoring. Standardised meals 
were provided. 
Results: Compared with Condition 1 (6.7±0.8 mmol·L-1·3.5 h-1), post-breakfast glucose iAUC was 
reduced for Condition 3 (3.5±0.9 mmol·L-1·3.5 h-1, p˂0.04). Post-lunch glucose iAUC was lower in 
Condition 3 (1.3±0.9 mmol·L-1·3.5 h-1, p˂0.03) and Condition 2 (2.1±0.7 mmol·L-1·3.5 h-1, p˂0.05) 
relative to Condition 1 (4.6±0.8 mmol·L-1·3.5 h-1). Condition 3 (1.0±0.7 mmol·L-1·3.5 h-1, p=0.02) and 
Condition 2 (1.6±0.6 mmol·L-1·3.5 h-1, p˂0.04) attenuated post-dinner glucose iAUC compared with 
Condition 1 (4.0±0.7 mmol·L-1·3.5 h-1). Cumulative 10.5-h postprandial glucose iAUC was lower in 
Condition 3 than Condition 1 (p=0.02). Condition 3 reduced 21-h glucose AUC compared with Condition 
1 (p<0.001) and Condition 2 (p=0.002). However, post-breakfast glucose iAUC, cumulative 10.5-h 
postprandial glucose iAUC and 21-h glucose AUC were not different between Condition 2 and Condition 
1 (p˃0.05). 
Conclusions: There could be dose-response between frequency of breaks in sedentary time and glucose. 
Interrupting sedentary time every 15 min could produce better glucose control. 
Clinical trial registration: Clinicaltrials.gov Identifier: NCT02738996 
Keywords: Diabetes mellitus; Glucose; Sedentary lifestyle; Exercise. 
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1. Introduction 
In type 2 diabetes, postprandial glucose control is crucial to reduce the risk of cardiovascular 
complications and all-cause mortality.1,2 However, even in people with type 2 diabetes with the 
recommended HbA1c (glycated haemoglobin) of less than 7% (53 mmol/mol), a high incidence of 
postprandial hyperglycaemia is detected.3 The management of postprandial glucose is challenging with 
standard diet modification and anti-diabetes agents,2 and new approaches need to be explored. 
One potential therapeutic target is the reduction of prolonged sedentary time. Any waking activity in 
sitting or reclining posture with low energy expenditure is defined as sedentary behaviour.4 Exposure to 
sedentary time has deleterious associations with 2-h postprandial glucose, daily glucose, cardiovascular 
diseases and mortality in healthy people and those with type 2 diabetes.5–7 The detrimental association 
between sedentary time and postprandial glucose is independent of physical activity and waist 
circumference.5,8 Sedentary time is also related to high insulin concentration and insulin resistance in 
people with newly diagnosed type 2 diabetes.9 Persistent increase in insulin concentration and insulin 
resistance related to prolonged sedentary time indicate overworked pancreatic β cells, which could lead to 
β cells exhaustion.10 
In contrast, interrupting sedentary time with short walking breaks (≤3 min) every 20 min or 30 min was 
shown experimentally to reduce postprandial glucose, daily glucose and insulin resistance compared to 
uninterrupted sitting (5-7 hours) in healthy people and those with type 2 diabetes.10–12 Consequently, 
promoting walking breaks in sedentary time appears to be a simple therapeutic intervention to control 
postprandial glucose and daily glucose. However, previous studies have always used uninterrupted sitting 
(5-7 hours) as the reference condition, which is rarely seen in real life, and dose-response between 
frequency of breaks in sedentary time and glucose control in type 2 diabetes is unknown. The aim of this 
proof of concept trial is to investigate if there is a dose-response between the frequency of light-intensity 
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walking breaks in sedentary time and postprandial glucose and daily glucose to understand how often 
sedentary time should be interrupted to provide therapeutic effects. 
2. Methods 
This study is an extension of a previously published randomised crossover trial.13 The study design was a 
three-treatment, two-period balanced incomplete block trial, which allows us to get evidence efficiently in 
a short time scale.14 This study was approved by the Research Ethics Committees of Glasgow Caledonian 
University and University of Strathclyde. This study conformed to the Declaration of Helsinki, and 
written informed consent was obtained from all participants.  
As previously reported,13 participants were randomised to two of the following three treatment conditions: 
sitting for 7 hours interrupted by 3 min light-intensity walking breaks every (1) 60 min (Condition 1), (2) 
30 min (Condition 2), and (3) 15 min (Condition 3) (Supplemental Fig. 1). Individuals (aged ≥35 years) 
with self-reported type 2 diabetes and body mass index (BMI) ≥25 kg/m2 were recruited between January 
2017 and June 2017 from the Glasgow community. Exclusion criteria included pregnancy, alcohol and 
substance abuse, insulin therapy, liver and renal diseases, cancer, mobility issues and diabetes-related 
complications such as foot ulcer, foot deformity, peripheral neuropathy and peripheral arterial diseases.  
The study protocol lasted 15 days (Supplemental Fig. 2) during which each participant completed two of 
three treatment conditions on weekdays. Participants were requested to abstain from smoking, alcohol and 
moderate to vigorous physical activity (MVPA) throughout study period and were additionally requested 
to avoid caffeine on treatment condition day. Habitual lifestyle and diet were maintained during pre-
experimental monitoring period, wash-out period and post-experimental monitoring period. The 
researcher stayed in touch with participants using participants’ preferred mode of communications (phone 
or email) to issue reminders and to schedule appointments. The details of study protocol were as follows: 
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Visit 1: On day 1, participants were requested to visit the university laboratory. Anthropometric data (age, 
gender, height, weight, waist circumference and BMI), blood pressure and drug history were recorded by 
the researcher. As previously described,13 a continuous glucose monitoring (CGM, Abbott FreeStyle 
Libre) and activPAL3 activity monitor (PAL Technologies, Glasgow, UK) were attached. Sleep diary and 
24-hour Dietary Recall Form were provided to record bedtime, waking time, dietary intake and 
medication throughout study period. Participants were instructed to scan glucose every 8 h using the 
FreeStyle Libre reader throughout study period. Participants then returned home and completed 4 days of 
pre-experimental monitoring period. 
Visit 2: On day 5, participants arrived at the laboratory at 0800 h after an overnight fast to perform the 
first treatment condition. Participants were seated from 0800 to 0900 h to achieve a physiological steady 
state. They had access to books, a personal computer and the internet. At 0900 h, participants consumed a 
standardised breakfast with 50-53.7 g carbohydrate, 9.1-12.6 g fat and 14.7-22.4 g protein. After 
breakfast, participants performed 3 min light-intensity walking breaks either every 60 min, 30 min or 15 
min of sitting depending on the condition they were randomised to. Light-intensity walking breaks were 
performed on level ground at a pace of 10 meters in 11 seconds (3.2 km/h). The researcher supervised the 
experiment and gave timing to participants to ensure that participants walked at required pace and 
performed all breaks in each condition. At 1236 h, a standardised lunch providing 75 g carbohydrate, 14.5 
g fat and 28 g protein was served. The laboratory condition was finished at 1600 h. A ready meal dinner 
with 50.1-55.6 g carbohydrate, 7.3-12.3 g fat and 20.1-30.1 g protein and a snack (bread, apple or plum) 
with 10-13.1 g carbohydrate, 0.3-0.6 g fat and 0.3-2.6 g protein were also provided for participants to 
consume at home on that evening.  
Visit 3: On day 11, participants performed the second treatment condition and were invited to the 
laboratory at 0800 h, having fasted overnight. Procedure of the second treatment condition was the same 
as the first treatment condition; however, a different treatment condition was performed. Participants 
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consumed identical breakfast, lunch, dinner and snack on both treatment condition days, and meal time 
and medication time were also standardised. There were five days of wash-out period between the first 
and second treatment conditions. 
Visit 4: The period between day 12 and day 15 was regarded as post-experimental monitoring period. On 
day 15, participants reported back to the laboratory for the removal of the CGM and activPAL3, and this 
was the end of participants’ participation.  
Physical activity and sedentary behaviour were monitored using the activPAL3. This small device was 
attached to the anterior aspect of the thigh using waterproof plastic tubing and hypoallergenic dressing. 
This device records the start and duration of sitting, lying, standing and walking for up to two weeks. It is 
a validated device and has been used in clinical trials and large epidemiological studies.6,13 Participants 
were asked to wear the device continuously for 15 days of the experimental period. The data were 
downloaded using activPAL3TM software (version 7.2.32). For each treatment condition day, estimated 
energy expenditure (metabolic equivalents, MET) was computed using the 24-h activPAL data. The sleep 
diary and activPAL files were used to remove sleeping time on treatment condition day, and the 
laboratory and 24-h sedentary time, standing time and walking time on treatment condition day were then 
calculated.13  
Glucose was monitored continuously using the CGM, consisting of a sensor worn on the back of the 
upper arm and a glucose reader. This is a validated device, which accurately records the interstitial 
glucose level every 15 minutes for up to two weeks.15 The glucose data were retrieved wirelessly by 
holding the reader close to the sensor for a few seconds. The glucose data from this device were 
downloaded to a personal computer using FreeStyle Libre software (version 1.0).  
For primary outcome measures, 3.5-h postprandial glucose incremental area under the curve (iAUC) was 
calculated for each meal (post-breakfast glucose iAUC, post-lunch glucose iAUC and post-dinner glucose 
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iAUC) and cumulative 10.5-h postprandial glucose. The glucose iAUCs were calculated by subtracting 
fasting glucose from overall postprandial glucose levels and using the trapezium rule.14 Average glucose 
between 0800 and 0900 h (steady state) was considered as fasting glucose. The period between 0900 h on 
treatment condition day and 0900 h on the following day was considered as the 24-hour period. Instead of 
24-h glucose total area under the curve (AUC), 21-h glucose AUC was calculated using the glucose 
obtained between 0900 h on treatment condition day and 0600 h on the following day because 
participants consumed breakfast around 0700 h on the following day. 
Block randomisation sequence was generated using SPSS by a blinded researcher, and order was 
allocated according to this sequence. Participants were then randomised to one of six possible trial-
condition orders (Supplemental Fig. 1). Each participant completed two of three treatment conditions and 
was blinded to trial-condition order until the first treatment condition day.  
Sample size calculations have been described previously.13 Across all experimental conditions and 
participants, 5.1 % of glucose values (108 of 2136 glucose points) were missing. Within-individual mean 
substitution was used to deal with missing glucose data.16 Differences in glucose variables between 
treatment conditions were assessed by multilevel mixed-effects linear regression with the repeated 
measurements for the same individuals. Treatment condition and participant were respectively used as a 
fixed factor and a random factor in these models. The models were adjusted for age (years), sex, waist 
circumference (cm), anti-diabetes medication dose (mg/day) and carbohydrate intake (g/day), sedentary 
time (h/day), standing time (h/day), walking time (h/day) and energy expenditure (MET x h/day) on the 
laboratory condition day. Sedentary time, standing time, walking time, energy expenditure and energy 
intake differences between treatment conditions were also analysed using multilevel mixed-effects linear 
regression. Pairwise comparisons between treatment conditions were conducted using post hoc Fisher 
LSD test, which has been recommended to identify differences between three treatment conditions.17 This 
test has been shown to produce greater statistical power and control Type I error when there are three 
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treatment conditions.17 The level of statistical significance was set at p value ≤0.05. Data are reported as 
mean±SE unless otherwise stated. IBM SPSS Statistics software (version 24.0) was used to perform 
statistical analyses.  
3. Results 
Table 1 reports baseline demographic and anthropometric data. Twelve participants with type 2 diabetes 
completed treatment conditions and were included in the analysis (Supplemental Fig. 1). The laboratory 
and 24-h sedentary time, standing time, walking time, energy expenditure and energy intake during 
treatment condition days are described in Table 2. During the laboratory period, walking time was 
significantly higher in Condition 3 and Condition 2 than Condition 1. On treatment condition days, the 
24-h walking time and energy expenditure were higher in Condition 3 than Condition 2 and Condition 1. 
The mean postprandial glucose iAUC and 21-h glucose AUC are reported in Fig. 1. Post-breakfast 
glucose iAUC was significantly attenuated in Condition 3 (3.5±0.9 mmol·L-1·3.5 h-1, p˂0.04) but not in 
Condition 2 (5.8±0.8 mmol·L-1·3.5 h-1, p=0.418) compared with Condition 1 (6.7±0.8 mmol·L-1·3.5 h-1). 
There was significant attenuation of post-lunch glucose iAUC in Condition 3 (1.3±0.9 mmol·L-1·3.5 h-1, 
p˂0.03) and Condition 2 (2.1±0.7 mmol·L-1·3.5 h-1, p˂0.05) relative to Condition 1 (4.6±0.8 mmol·L-
1·3.5 h-1). Compared with Condition 1 (4.0±0.7 mmol·L-1·3.5 h-1), both Condition 3 (1.0±0.7 mmol·L-
1·3.5 h-1, p=0.02) and Condition 2 (1.6±0.6 mmol·L-1·3.5 h-1, p˂0.04) significantly reduced post-dinner 
glucose iAUC. Cumulative 10.5-h postprandial glucose iAUC was significantly attenuated in Condition 3 
(5.6±2.4 mmol·L-1·10.5 h-1, p=0.02) but not in Condition 2 (9.1±2.0 mmol·L-1·10.5 h-1, p=0.066) relative 
to Condition 1 (14.8±2.2 mmol·L-1·10.5 h-1). Compared with Condition 1 (153.7±5.7 mmol·L-1·21 h-1), 
significant reduction in 21-h glucose AUC was observed with Condition 3 (101.5±12.6 mmol·L-1·21 h-1, 
p<0.001) but not with Condition 2 (136.2±10.6 mmol·L-1·21 h-1, p=0.08). Moreover, 21-h glucose AUC 
was significantly reduced in Condition 3 relative to Condition 2 (p=0.002). However, no significant 
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differences between Condition 3 and Condition 2 were observed for the remaining glucose outcome 
measures (p≥0.089).  
4. Discussion 
This study demonstrates that there could be the dose-response between the frequency of light-intensity 
walking breaks in sedentary time and postprandial glucose and daily glucose in people with type 2 
diabetes. This study showed that interrupting sedentary time every 15 min (Condition 3) reduced post-
breakfast glucose (48%), cumulative postprandial glucose (62%) and 21-h glucose (34%) relative to 
interrupting sedentary time every 60 min (Condition 1). Interrupting sedentary time every 15 min 
(Condition 3) also reduced 21-h glucose (25%) compared with interrupting sedentary time every 30 min 
(Condition 2). Compared with walking breaks every 60 min, interrupting sedentary time every 30 min and 
15 min attenuated post-lunch glucose (54% in Condition 2, 72% in Condition 3) and post-dinner glucose 
(60% in Condition 2, 75% in Condition 3). 
The magnitude of cumulative postprandial glucose reduction (39%) after Condition 2 compared with 
Condition 1 in this study is similar to a previous study, which reported 39% reduction after 3 min light-
intensity walking breaks every 30 min.12 In this study, Condition 3 performed more breaks and showed an 
expected larger effect on cumulative postprandial glucose reduction (62%) than previous studies 
conducted in overweight and obese adults (24% in 2 min walking breaks every 20 min), overweight and 
obese postmenopausal women (28% in 5 min walking breaks every 30 min), normal weight adults (39% 
in 1 min 40 s walking breaks every 30 min) and overweight and obese adults with type 2 diabetes (39% in 
3 min walking breaks every 30 min).10,12,14,18  
There is epidemiological evidence that post-breakfast glucose and post-lunch glucose can predict the risk 
of cardiovascular complications.1 Post-breakfast glucose has a slightly stronger association with HbA1c 
than post-lunch glucose, and post-dinner glucose has no effect on HbA1c.19 Therefore, post-breakfast 
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glucose and post-lunch glucose are clinically important. However, high post-breakfast is consistently 
observed in type 2 diabetes.19,20 It is more common than high post-lunch glucose and post-dinner glucose 
because the circadian glycaemic profile tends to be the highest after breakfast.19,20 The present study 
suggests that interrupting sedentary time every 15 min with light-intensity walking breaks should be 
recommended to improve post-meal glucose, particularly for post-breakfast glucose, in type 2 diabetes.  
This study also demonstrated that interrupting sedentary time every 15 min could produce progressive 
postprandial glucose reduction, and this is in agreement with a previous study, which observed greater 
reduction in post-dinner glucose with 10 min post-meal walking than post-breakfast glucose and post-
lunch glucose.21 The effect of interrupting sedentary time every 15 min observed in this study seems 
comparable to that of anti-diabetes agents such as metformin.22 Moreover, 21-h glucose reduction in 
Condition 3 indicates that interrupting sedentary time every 15 min could improve daily glucose control, 
which is associated with HbA1c.23 We therefore suggest that interrupting sedentary time every 15 min 
(Condition 3) in addition to oral anti-diabetes agents might be an effective strategy to improve clinical 
outcomes.  
A strength of this study is to use a much more ecologically valid design compared to previous studies. In 
previous studies, the reference condition had always been uninterrupted sitting (5-7 hours).10,12,24 Instead, 
this study used interrupting sedentary time every 60 min as the reference condition, which is closer to 
habitual sedentary pattern of people with type 2 diabetes.25 A recent study investigated postprandial 
metabolic responses to the frequency of standing breaks in normoglycaemic overweight/obese men; 
however, the reference condition was uninterrupted sitting for 8 hours.24 Therefore, the present study 
provided, for the first time in people with type 2 diabetes, evidence on the dose-response of different 
frequencies of walking breaks on postprandial glucose and daily glucose. Another strength is that 
participants were asked to walk on level ground instead of walking on treadmill. It is believed that 
treadmill walking does not represent habitual walking because its energy expenditure tends to be higher 
AC
CE
PT
ED
 M
AN
US
CR
IPT
11 
 
than habitual walking with the same speed.26 In addition, the use of CGM and activPAL3 is a strength of 
this study, and real-time glucose and objectively measured activity/sedentary behaviour were reported. 
The present study has some limitations. First, a small sample size was used in this study. However, 
sample size calculations were conducted, and previous studies with similar study designs had also used 
the small sample size (n=9-10).27,28 Using the sample with type 2 diabetes in our study could find greater 
effect of interrupting sedentary time than previous studies using the sample without type 2 
diabetes.10,24,28,29 Because, it is suggested that the beneficial effects of interrupting sedentary time on 
glucose control could be proportional to higher underlying levels of insulin resistance.29 Second, adjusting 
for a relatively large number of covariates might lead to over-adjustment. However, this could be 
minimised because covariates used in this study could influence glucose outcomes, and the effect of 
treatment conditions were observed.6,13,14,30 Third, time frame of adjusted sedentary time (h/day), standing 
time (h/day), walking time (h/day) and energy expenditure (MET x h/day) in the models were not the 
same as glucose outcomes. Fourth, participants were not provided with standardised dinner prior to the 
laboratory conditions. Fifth, the effect of breaks performed at different times of the day (e.g. morning vs. 
evening) might be vary,21 and this should be tested in future studies. Sixth, daily energy requirement for 
each participant was not calculated, and standardised meals were not based on their energy requirements. 
Seventh, total sitting time was not matched between treatment conditions. It is not fully understood if it is 
the frequency of breaks or the reduction of sitting time or change in energy expenditure, which produces 
the beneficial effects. Nevertheless, statistical analyses were adjusted for carbohydrate intake, sedentary 
time, total activity time and energy expenditure, and the frequency of breaks in sedentary time could have 
the dose-response relationship with glucose control. Finally, wearable devices such as the CGM and 
activPAL3 might influence participants’ eating behaviour and physical activity patterns in the evening 
after treatment condition and during pre-experimental monitoring period, wash-out period and post-
experimental monitoring period. 
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5. Conclusion 
This study suggests that more frequent interruption of sedentary time (at least every 15 min) could 
achieve better postprandial glucose and daily glucose control. The combination of interrupting sedentary 
time every 15 min and anti-diabetes agents may be effective to reduce HbA1c and diabetes-related 
complications. The feasibility and clinical effects of interrupting sedentary time every 15 min in free-
living settings should be evaluated in future long-term studies.  
Practical implications 
 There could be a dose-response relationship between the frequency of interruption of sitting time 
and glucose control.  
 Interrupting sitting time every 15 min rather than every 30 min produces better glucose control, 
particularly for post-breakfast glucose and 21-h glucose. 
 Interrupting sitting time at least every 15 min could be used in conjunction with anti-diabetes 
agents to improve clinical outcomes in type 2 diabetes. 
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Figure legends 
 
Fig. 1. The effect of three treatment conditions on post-breakfast glucose iAUC (a); post-lunch glucose 
iAUC (b); post-dinner glucose iAUC (c); cumulative 10.5-h postprandial glucose iAUC (d); and 21-h 
glucose AUC (e). Data represents means±SE. *Significantly lower compared with Condition 1 (p<0.05). 
†Significantly lower compared with Condition 2 (p=0.002). PPG, postprandial glucose. 
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Data are means±SD or n (%). BMI, body mass index; ACEI, angiotensin converting enzyme inhibitor; 
ARB, angiotensin receptor blocker. 
Table 1 Demographic and anthropometric characteristics of participants. 
Baseline characteristics  
Total number of participants (n) 12 
Men/Women (n) 8/4 
Age (years) 60±11 
Waist circumference (cm) 102.1±13.5 
BMI (kg/m2) 30.2±4.7 
Duration of diabetes (years) 5.2±2.9 
Smoking status, n (%)  
   Non-smoker 11 (92%) 
   Smoker 1 (8 %) 
Diabetes management, n (%)  
   Diet and lifestyle modification 1 (8.3%) 
   Metformin 7 (58%) 
   Metformin + Gliclazide 4 (33%) 
Other medications, n (%)  
   Statin 5 (41%) 
   Calcium channel blocker 2 (16%) 
   ACEI 2 (16%) 
   ARB 2 (16%) 
   β blocker 1 (8%) AC
CE
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Data are presented means±SE. *Significantly different from Condition 1 (p˂0.04).  
†Significantly different from Condition 2 (p≤0.02). EE, energy expenditure.  
Table 2  
Sedentary time, activity time, energy expenditure and energy intake on treatment condition days. 
Variables Condition 1 
(n=8) 
Condition 2 
(n=8) 
Condition 3 
(n=8) 
Laboratory sedentary and activity time    
   Sedentary time (h/day) 7.3±0.3 6.9±0.3 6.5±0.3* 
   Standing time (h/day) 0.4±0.2 0.5±0.2 0.4±0.2 
   Walking time (h/day) 0.4±0.02 0.7±0.02* 1.2±0.02*† 
24-h sedentary and activity time    
   Sedentary time (h/day) 12.0±0.3 12.3±0.3 12.7±0.3 
   Standing time (h/day) 2.4±0.4 2.6±0.5 1.8±0.1 
   Walking time (h/day) 1.4±0.1 1.6±0.1 2.1±0.1*† 
Estimated EE (MET x h/day) 33.3±1.3 33.6±0.3 34.7±0.2*† 
Energy intake (kJ/day) 5480.6±37.9 5474.3±31.9 5479.9±37.8 
Carbohydrate (energy %) 54.6±0.4 54.7±0.3 54.6±0.3 
Fat (energy %) 23.1±0.2 23.1±0.2 23.1±0.2 
Protein (energy %) 22.3±0.2 22.3±0.2 22.3±0.2 
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